Analgesic medicines for adults with low back pain: protocol for a systematic review and network meta-analysis

Syst Rev. 2020 Nov 4;9(1):255. doi: 10.1186/s13643-020-01506-3.

Abstract

Background: There is limited evidence for the comparative effectiveness of analgesic medicines for adults with low back pain. This systematic review and network meta-analysis aims to determine the analgesic effect, safety, acceptability, effect on function, and relative rank according to analgesic effect, safety, acceptability, and effect on function of a single course of [an] analgesic medicine(s) or combination of these medicines for people with low back pain.

Methods: We will include published and unpublished randomised trials written in any language that compare an analgesic medicine to either another medicine, placebo/sham, or no intervention in adults with low back pain, grouped according to pain duration: acute (fewer than 6 weeks), sub-acute (6 to 12 weeks), and chronic (greater than 12 weeks). The co-primary outcomes are pain intensity following treatment and safety (adverse events). The secondary outcomes are function and acceptability (all-cause dropouts). We will perform a network meta-analysis to compare and rank analgesic medicines. We will form judgements of confidence in the results using the Confidence in Network Meta-Analysis (CINeMA) methodology.

Discussion: This network meta-analysis will establish which medicine, or combination of medicines, is most effective for reducing pain and safest for adults with low back pain.

Systematic review registration: PROSPERO CRD42019145257.

Keywords: Analgesics [MeSH]; Low back pain [MeSH]; Meta-analysis as topic [MeSH]; Network meta-analysis [MeSH]; Systematic reviews as topic [MeSH].

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Analgesics / therapeutic use
  • Humans
  • Low Back Pain* / drug therapy
  • Meta-Analysis as Topic
  • Network Meta-Analysis
  • Systematic Reviews as Topic

Substances

  • Analgesics